IS6661A - Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun - Google Patents

Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun

Info

Publication number: IS6661A
Authority: IS; Iceland
Prior art keywords: preparation; therapeutic use; benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2000-08-08

Application number

IS6661A

Other languages

English (en)

Inventor

Barth Francis

Bichon Daniel

Bolkenius Frank

Van Dorsselaer Viviane

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-08

Filing date

2002-12-19

Publication date

2002-12-19

2000-08-08 Priority claimed from FR0010419A external-priority patent/FR2812878B1/fr

2000-11-15 Priority claimed from FR0014696A external-priority patent/FR2816619B1/fr

2002-12-19 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2002-12-19 Publication of IS6661A publication Critical patent/IS6661A/is

Links

229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Virology (AREA)
Transplantation (AREA)
Obesity (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Psychiatry (AREA)
AIDS & HIV (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)

IS6661A 2000-08-08 2002-12-19 Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun IS6661A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0010419A FR2812878B1 (fr)	2000-08-08	2000-08-08	Derives de benzimidazole, leur preparation et leur application en therapeutique
FR0014696A FR2816619B1 (fr)	2000-11-15	2000-11-15	Derives de benzimidazole, leur preparation et leur application en therapeutique
PCT/FR2001/002556 WO2002012239A1 (fr)	2000-08-08	2001-08-06	Derives de benzimidazole, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
IS6661A true IS6661A (is)	2002-12-19

Family

ID=26212570

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6661A IS6661A (is)	2000-08-08	2002-12-19	Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun

Country Status (27)

Country	Link
US (2)	US6794382B2 (is)
EP (1)	EP1309594B1 (is)
JP (1)	JP2004505975A (is)
KR (1)	KR20030020450A (is)
CN (1)	CN1446218A (is)
AR (1)	AR030121A1 (is)
AT (1)	ATE284886T1 (is)
AU (1)	AU2001282267A1 (is)
BG (1)	BG107460A (is)
BR (1)	BR0113046A (is)
CA (1)	CA2412368A1 (is)
CZ (1)	CZ294493B6 (is)
DE (1)	DE60107859T2 (is)
EA (1)	EA005950B1 (is)
EE (1)	EE200300048A (is)
ES (1)	ES2233671T3 (is)
HR (1)	HRP20030081A2 (is)
HU (1)	HUP0301514A2 (is)
IL (1)	IL153708A0 (is)
IS (1)	IS6661A (is)
MX (1)	MXPA03000753A (is)
NO (1)	NO20030596L (is)
PL (1)	PL365080A1 (is)
PT (1)	PT1309594E (is)
SK (1)	SK1582003A3 (is)
WO (1)	WO2002012239A1 (is)
YU (1)	YU7203A (is)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050119251A1 (en) *	2001-12-21	2005-06-02	Jian-Min Fu	Nicotinamide derivatives and their use as therapeutic agents
US20040014744A1 (en) *	2002-04-05	2004-01-22	Fortuna Haviv	Substituted pyridines having antiangiogenic activity
WO2003103666A2 (en) *	2002-06-07	2003-12-18	Altana Pharma Ag	Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
AU2003240742A1 (en) *	2002-06-07	2003-12-22	Altana Pharma Ag	4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors
WO2004108723A1 (en) *	2003-06-04	2004-12-16	Altana Pharma Ag	4,5-dihydro-imidazo[4,5,1-ii]quinolin-6-ones as parp inhibitors
GB0317466D0 (en)	2003-07-25	2003-08-27	Univ Sheffield	Use
SG150548A1 (en)	2003-12-01	2009-03-30	Kudos Pharm Ltd	Dna damage repair inhibitors for treatment of cancer
CN101083986A (zh) *	2004-09-20	2007-12-05	泽农医药公司	双环杂环衍生物及其作为硬脂酰CoA去饱和酶(SCD)抑制剂的用途
EP2316458A1 (en) *	2004-09-20	2011-05-04	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
EP2289510A1 (en)	2004-09-20	2011-03-02	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
US7767677B2 (en)	2004-09-20	2010-08-03	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP1799667B1 (en) *	2004-09-20	2013-03-20	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
US7951805B2 (en) *	2004-09-20	2011-05-31	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1804799B1 (en) *	2004-09-20	2013-08-21	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580856A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
JP4958787B2 (ja) *	2004-09-20	2012-06-20	ゼノン・ファーマシューティカルズ・インコーポレイテッド	ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリジン誘導体
EP2319512A1 (en) *	2005-01-11	2011-05-11	NeuroSearch AS	Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels.
EP2029138A1 (en) *	2005-06-03	2009-03-04	Xenon Pharmaceuticals Inc.	Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
MX2008001152A (es) *	2005-08-05	2008-04-02	Astrazeneca Ab	Benzimidazoles triciclicos y su uso como moduladores del receptor de glutamato metabotropico.
JP2009541454A (ja) *	2006-07-03	2009-11-26	ノイロサーチアクティーゼルスカブ	モノアミン再摂取阻害剤及びカリウムチャネル活性剤の併用
GB0716532D0 (en)	2007-08-24	2007-10-03	Angeletti P Ist Richerche Bio	Therapeutic compounds
GB201220157D0 (en) *	2012-11-08	2012-12-26	Selvita Sa	Substitute tricyclic benzimidazoles as kinase inhibitors
CN103923088B (zh) *	2013-01-11	2016-09-07	上海汇伦生命科技有限公司	2,5-二氮杂双环[2.2.1]庚烷类化合物和制备方法、其药用组合物及其在医药上的应用
EA035469B1 (ru) *	2013-03-15	2020-06-22	Инсайт Холдингс Корпорейшн	Трициклические гетероциклы как ингибиторы белков бэт
CN104230896A (zh) *	2013-06-17	2014-12-24	上海汇伦生命科技有限公司	苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途
US9309246B2 (en)	2013-12-19	2016-04-12	Incyte Corporation	Tricyclic heterocycles as BET protein inhibitors
SMT202000133T1 (it)	2014-04-23	2020-05-08	Incyte Corp	1h-pirrolo[2,3-c]piridin-7(6h)-oni e pirazolo[3,4-c]piridin-7(6h)-oni come inibitori di proteine bet
AU2016271762B2 (en) *	2015-05-29	2020-01-23	Shionogi & Co., Ltd.	Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity
CN109715625B (zh)	2016-06-20	2022-04-19	因赛特公司	Bet抑制剂的结晶固体形式
CN110661676B (zh) *	2018-06-29	2022-06-28	大唐移动通信设备有限公司	一种带宽部分的测量方法、配置方法、终端及网络设备
CN111349094B (zh) *	2020-04-23	2021-02-02	杭州师范大学	一种6H-咪唑[4,5,1-ij]并喹诺酮及其合成方法和应用
US11833155B2 (en)	2020-06-03	2023-12-05	Incyte Corporation	Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2710915B1 (fr)	1993-10-04	1995-11-24	Synthelabo	Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
FR2731708B1 (fr) *	1995-03-13	1997-04-30	Synthelabo	Derives de piperidine, leur procede de preparation et leur application en therapeutique
DK1133477T3 (da)	1998-11-27	2004-06-21	Abbott Gmbh & Co Kg	Substituerede benzimidazoler og deres anvendelse som parpinhibitorer

2001
- 2001-08-06 HR HR20030081A patent/HRP20030081A2/hr not_active Application Discontinuation
- 2001-08-06 US US10/343,467 patent/US6794382B2/en not_active Expired - Fee Related
- 2001-08-06 HU HU0301514A patent/HUP0301514A2/hu unknown
- 2001-08-06 PL PL01365080A patent/PL365080A1/xx not_active Application Discontinuation
- 2001-08-06 YU YU7203A patent/YU7203A/sh unknown
- 2001-08-06 AR ARP010103751A patent/AR030121A1/es not_active Application Discontinuation
- 2001-08-06 JP JP2002518214A patent/JP2004505975A/ja active Pending
- 2001-08-06 MX MXPA03000753A patent/MXPA03000753A/es unknown
- 2001-08-06 DE DE60107859T patent/DE60107859T2/de not_active Expired - Lifetime
- 2001-08-06 PT PT01960871T patent/PT1309594E/pt unknown
- 2001-08-06 EA EA200201259A patent/EA005950B1/ru not_active IP Right Cessation
- 2001-08-06 WO PCT/FR2001/002556 patent/WO2002012239A1/fr not_active Ceased
- 2001-08-06 AU AU2001282267A patent/AU2001282267A1/en not_active Abandoned
- 2001-08-06 CZ CZ2003354A patent/CZ294493B6/cs not_active IP Right Cessation
- 2001-08-06 KR KR10-2003-7001760A patent/KR20030020450A/ko not_active Withdrawn
- 2001-08-06 IL IL15370801A patent/IL153708A0/xx unknown
- 2001-08-06 AT AT01960871T patent/ATE284886T1/de not_active IP Right Cessation
- 2001-08-06 EP EP01960871A patent/EP1309594B1/fr not_active Expired - Lifetime
- 2001-08-06 SK SK158-2003A patent/SK1582003A3/sk unknown
- 2001-08-06 ES ES01960871T patent/ES2233671T3/es not_active Expired - Lifetime
- 2001-08-06 BR BR0113046-3A patent/BR0113046A/pt not_active IP Right Cessation
- 2001-08-06 CN CN01813895A patent/CN1446218A/zh active Pending
- 2001-08-06 CA CA002412368A patent/CA2412368A1/fr not_active Abandoned
- 2001-08-06 EE EEP200300048A patent/EE200300048A/xx unknown
2002
- 2002-12-19 IS IS6661A patent/IS6661A/is unknown
2003
- 2003-01-14 BG BG107460A patent/BG107460A/bg unknown
- 2003-02-06 NO NO20030596A patent/NO20030596L/no not_active Application Discontinuation
2004
- 2004-09-13 US US10/939,910 patent/US20050032779A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1309594E (pt)	2005-04-29
CZ2003354A3 (cs)	2003-05-14
US20030203893A1 (en)	2003-10-30
CZ294493B6 (cs)	2005-01-12
DE60107859T2 (de)	2005-12-22
US20050032779A1 (en)	2005-02-10
EP1309594A1 (fr)	2003-05-14
KR20030020450A (ko)	2003-03-08
HK1053118A1 (en)	2003-10-10
WO2002012239A1 (fr)	2002-02-14
CA2412368A1 (fr)	2002-02-14
JP2004505975A (ja)	2004-02-26
CN1446218A (zh)	2003-10-01
BR0113046A (pt)	2003-07-01
HRP20030081A2 (en)	2005-02-28
HUP0301514A2 (hu)	2003-09-29
DE60107859D1 (de)	2005-01-20
US6794382B2 (en)	2004-09-21
IL153708A0 (en)	2003-07-06
EE200300048A (et)	2004-12-15
AR030121A1 (es)	2003-08-13
EA200201259A1 (ru)	2003-06-26
NO20030596D0 (no)	2003-02-06
SK1582003A3 (en)	2003-08-05
NO20030596L (no)	2003-04-01
AU2001282267A1 (en)	2002-02-18
EA005950B1 (ru)	2005-08-25
ES2233671T3 (es)	2005-06-16
MXPA03000753A (es)	2003-10-15
BG107460A (bg)	2003-09-30
ATE284886T1 (de)	2005-01-15
EP1309594B1 (fr)	2004-12-15
PL365080A1 (en)	2004-12-27
YU7203A (sh)	2006-01-16

Publication	Publication Date	Title
NO20030596D0 (no)	2003-02-06	Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
NO20012567D0 (no)	2001-05-25	Azepinoindolderivater, fremstilling og anvendelse derav
NO20021379D0 (no)	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav
IS2485B (is)	2008-12-15	Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
DK1177178T3 (da)	2005-05-02	Heterocyclisk substituerede benzimidazoler, deres fremstilling og anvendelse
DK1095025T3 (da)	2003-04-07	Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1161434T3 (da)	2003-05-26	Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
DK1513836T3 (da)	2006-09-11	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
NO20031838D0 (no)	2003-04-24	Benzokazinonderivater, deres fremstilling og anvendelse
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
IS6420A (is)	2002-06-13	Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
TR200002099A3 (tr)	2001-06-21	Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari
DK1334106T3 (da)	2006-09-18	Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
DK1043307T3 (da)	2003-09-22	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20024107L (no)	2002-09-27	Tienopyridin derivater, deres fremstilling og anvendelse
IS2487B (is)	2008-12-15	Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
NO20001782D0 (no)	2000-04-06	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1309594T3 (da)	2005-04-25	Benzimidazolderivater, fremstilling heraf og terapeutisk anvendelse heraf
IS6391A (is)	2002-05-21	2-Arýlkínólín afleiður, framleiðsla og meðferðarleg notkun á þeim